| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 116.117 | 170.813 | 201.709 | 320.052 | 339.999 | 265.937 | 199.082 | 293.373 | 237.979 | 320.980 |
| Total Income - EUR | 116.468 | 171.292 | 201.805 | 320.207 | 340.174 | 266.016 | 199.083 | 293.379 | 237.981 | 320.983 |
| Total Expenses - EUR | 108.630 | 169.519 | 173.643 | 215.693 | 236.765 | 222.531 | 163.600 | 230.365 | 233.748 | 262.303 |
| Gross Profit/Loss - EUR | 7.838 | 1.773 | 28.162 | 104.513 | 103.409 | 43.485 | 35.483 | 63.014 | 4.233 | 58.680 |
| Net Profit/Loss - EUR | 6.972 | 1.336 | 26.004 | 101.311 | 100.081 | 40.819 | 33.492 | 60.079 | 1.853 | 49.051 |
| Employees | 17 | 17 | 17 | 18 | 20 | 18 | 16 | 15 | 15 | 15 |
Check the financial reports for the company - Amamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.596 | 18.406 | 18.094 | 25.967 | 27.287 | 34.357 | 33.595 | 35.316 | 42.677 | 42.439 |
| Current Assets | 12.536 | 11.061 | 39.599 | 134.993 | 230.546 | 169.513 | 118.029 | 85.674 | 16.001 | 68.238 |
| Inventories | 106 | 161 | 0 | 0 | 567 | 1.197 | 1.170 | 1.174 | 1.170 | 1.164 |
| Receivables | 6.659 | 6.456 | 7.377 | 129.962 | 224.967 | 167.010 | 105.211 | 66.273 | 9.535 | 60.591 |
| Cash | 5.771 | 4.444 | 32.222 | 5.031 | 5.012 | 1.306 | 11.648 | 18.227 | 5.295 | 6.484 |
| Shareholders Funds | 15.517 | 16.695 | 42.416 | 142.949 | 240.261 | 193.832 | 142.165 | 101.296 | 42.193 | 91.008 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.614 | 12.772 | 15.277 | 18.011 | 17.572 | 10.038 | 9.459 | 19.694 | 16.485 | 19.669 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Amamed S.r.l.